Fiduciary Alliance’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.45M Sell
10,591
-4,254
-29% -$600K 0.11% 184
2026
Q2
$2.18M Buy
14,845
+1,562
+12% +$283K 0.15% 165
2026
Q1
$2.26M Buy
13,283
+157
+1% +$25.5K 0.14% 170
2025
Q4
$2.56M Buy
13,126
+1,017
+8% +$242K 0.17% 139
2025
Q3
$3.41M Buy
12,109
+333
+3% +$84.8K 0.23% 99
2025
Q2
$2.57M Sell
11,776
-1,329
-10% -$215K 0.19% 118
2025
Q1
$1.83M Sell
13,105
-24,923
-66% -$4.06M 0.18% 115
2024
Q4
$6.34M Buy
38,028
+22,238
+141% +$3.95M 0.64% 42
2024
Q3
$2.69M Buy
+15,790
New +$2.29M 0.36% 71
2023
Q3
– Sell
-487
Closed -$58K – 685
2023
Q2
$58K Buy
+487
New +$50.4K 0.01% 289
2023
Q1
– Sell
-222
Closed -$18.2K – 623
2022
Q4
$18.2K Buy
+222
New +$16.9K ﹤0.01% 325

Other funds holding ORCL

Fiduciary Alliance's ORCL Position: Q3 2026 in Review

Fiduciary Alliance reduced its Oracle (ORCL) stake by 29% in Q3 2026, selling an estimated $600K and leaving 10,591 shares worth $1.45M. The position accounts for 0.11% of the portfolio, ranked #184.

Fiduciary Alliance first reported a position in ORCL in Q4 2022 and has held it in 11 quarters since. The position peaked at $6.34M in Q4 2024. 880 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • Fiduciary Alliance held 10,591 shares of Oracle worth $1.45M as of Q3 2026.
  • Fiduciary Alliance sold 4,254 Oracle shares in Q3 2026, an estimated $600K.
  • Oracle made up 0.11% of Fiduciary Alliance's portfolio in Q3 2026, its #184 holding.
  • Fiduciary Alliance first reported a position in Oracle in Q4 2022 and has held it in 11 quarters since.
  • Fiduciary Alliance's Oracle position peaked at $6.34M in Q4 2024.
  • 880 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on Fiduciary Alliance's 13F filing for Q3 2026, filed 13 Oct 2026.